Cargando…
Apomorphine and Levodopa Infusion Therapies for Advanced Parkinson’s Disease
Continuous infusion of levodopa or apomorphine provide constant dopaminergic stimulations are good alternatives to deep brain stimulation to control motor fluctuations in patients with advanced Parkinson’s disease (PD). Apomorphine provides motor benefit similar to dopamine, but its long-term use is...
Autor principal: | |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Korean Movement Disorder Society
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4027699/ https://www.ncbi.nlm.nih.gov/pubmed/24868344 http://dx.doi.org/10.14802/jmd.09002 |
_version_ | 1782316985726533632 |
---|---|
author | Antonini, Angelo |
author_facet | Antonini, Angelo |
author_sort | Antonini, Angelo |
collection | PubMed |
description | Continuous infusion of levodopa or apomorphine provide constant dopaminergic stimulations are good alternatives to deep brain stimulation to control motor fluctuations in patients with advanced Parkinson’s disease (PD). Apomorphine provides motor benefit similar to dopamine, but its long-term use is limited by compliance, mostly injection site skin reactions. Administration of levodopa/carbidopa by continuous duodenal infusion allows replacement of all oral medications and permits achievement of a satisfactory therapeutic response paralleled by a reduction in motor complication severity. However, this procedure is more invasive than apomorphine as it requires a percutaneous endoscopic gastrostomy Clinical experience with infusions shows that continuous dopaminergic stimulation of dopaminergic medications reduces dyskinesia and widens the therapeutic window in advanced PD. |
format | Online Article Text |
id | pubmed-4027699 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2009 |
publisher | The Korean Movement Disorder Society |
record_format | MEDLINE/PubMed |
spelling | pubmed-40276992014-05-27 Apomorphine and Levodopa Infusion Therapies for Advanced Parkinson’s Disease Antonini, Angelo J Mov Disord Invited Review Continuous infusion of levodopa or apomorphine provide constant dopaminergic stimulations are good alternatives to deep brain stimulation to control motor fluctuations in patients with advanced Parkinson’s disease (PD). Apomorphine provides motor benefit similar to dopamine, but its long-term use is limited by compliance, mostly injection site skin reactions. Administration of levodopa/carbidopa by continuous duodenal infusion allows replacement of all oral medications and permits achievement of a satisfactory therapeutic response paralleled by a reduction in motor complication severity. However, this procedure is more invasive than apomorphine as it requires a percutaneous endoscopic gastrostomy Clinical experience with infusions shows that continuous dopaminergic stimulation of dopaminergic medications reduces dyskinesia and widens the therapeutic window in advanced PD. The Korean Movement Disorder Society 2009-05 2009-04-30 /pmc/articles/PMC4027699/ /pubmed/24868344 http://dx.doi.org/10.14802/jmd.09002 Text en Copyright © 2009 The Korean Movement Disorder Society This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Invited Review Antonini, Angelo Apomorphine and Levodopa Infusion Therapies for Advanced Parkinson’s Disease |
title | Apomorphine and Levodopa Infusion Therapies for Advanced Parkinson’s Disease |
title_full | Apomorphine and Levodopa Infusion Therapies for Advanced Parkinson’s Disease |
title_fullStr | Apomorphine and Levodopa Infusion Therapies for Advanced Parkinson’s Disease |
title_full_unstemmed | Apomorphine and Levodopa Infusion Therapies for Advanced Parkinson’s Disease |
title_short | Apomorphine and Levodopa Infusion Therapies for Advanced Parkinson’s Disease |
title_sort | apomorphine and levodopa infusion therapies for advanced parkinson’s disease |
topic | Invited Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4027699/ https://www.ncbi.nlm.nih.gov/pubmed/24868344 http://dx.doi.org/10.14802/jmd.09002 |
work_keys_str_mv | AT antoniniangelo apomorphineandlevodopainfusiontherapiesforadvancedparkinsonsdisease |